NuvOx licenses stroke emulsion treatment from U. of Arkansas; Hovione files IND for topical acne med;

> NuvOx Pharma snagged an exclusive license from the University of Arkansas for a dodecafluoropentane emulsion that can reduce brain damage from stroke by over 80%. Release

> Hovione filed an investigational new drug application with the FDA for its minocycline gel, a topical delivery solution for the commonly used acne treatment. It would be the first such topical formulation approved. Release

Suggested Articles

Kala Pharma's Eysuvis on Tuesday became the first and only corticosteroid approved to treat short-term signs and symptoms of dry eye disease.

Xeris scored an FDA fast track designation for its diazepam formulation, delivered via autoinjector, to treat acute repetitive seizures.

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.